Stockwatch: The Perils of Forward Guidance
This article was originally published in Scrip
Executive Summary
After another record month for the biotechnology sector, there are signs that some investors are getting picky. It doesn't seem to be quite enough anymore just to be a biotech company: in addition, companies are expected to give exact guidance on their future.